4.6 Article

Akt2 and nucleophosmin/B23 function as an oncogenic unit in human lung cancer cells

期刊

EXPERIMENTAL CELL RESEARCH
卷 317, 期 7, 页码 966-975

出版社

ELSEVIER INC
DOI: 10.1016/j.yexcr.2010.12.013

关键词

Akt2; A549; Invasion; Nucleophosmin(B23); Proliferation; Tumorigenesis

资金

  1. National R&D Program for Cancer Control
  2. Ministry for Health, Welfare and Family Affairs, Republic of Korea [0720380]
  3. Korea Healthcare Technology RD Project
  4. Ministry for Health, Welfare & Family Affairs, Republic of Korea [A090118]
  5. Korea Health Promotion Institute [A090118] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

向作者/读者索取更多资源

The signaling network of protein kinase B(PKB)/Akt has been implicated in survival of lung cancer cells. However, understanding the relative contribution of the different isoform of Akt network is nontrival. Here, we report that Akt2 is highly expressed in human lung adenocarcinoma cell line A549 cells. Suppression of Akt2 expression in A549 cells results in notable inhibition of cell poliferation, soft agar growth, and invasion, accompanying by a decrease of nucleophosmin/B23 protein. Overexpression of Akt1 restores cancerous growth of A549 cells in B23-knockdown (KD) cells while Akt2 overexpression did not restore proliferating potential in cells with downregulated B23, thus suggesting Akt2 requires B23 to drive proliferation of lung cancer cell. Loss of functional Akt2 and B23 has similar defects on cell proliferation, apoptotic resistance and cell cycle regulation, while loss of Akt1 has less defects on cell proliferation, survial and cell cycle progression in A549 cells. Moreover, overexpression of 823 rescues the proliferative block induced as a consequence of loss of Akt2. Thus our data suggest that Akt2/B23 functions as an oncogenic unit to drive tumorigenesis of A549 lung cancer cells. (C) 2010 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据